Heart and lung transplantation in patients with end stage lung disease.Br Med J (Clin Res Ed) 1987; 295 doi: https://doi.org/10.1136/bmj.295.6593.311 (Published 01 August 1987) Cite this as: Br Med J (Clin Res Ed) 1987;295:311
- A Penketh,
- T Higenbottam,
- M Hakim,
- J Wallwork
Combined heart and lung transplantation was used to treat seven patients with end stage lung disease. All were severely disabled, and their disease carried a poor prognosis. Six patients were well four to 33 months after transplantation. One patient died after 44 days from a primary cytomegalovirus pneumonia transmitted from the donor. All the survivors had normal exercise tolerance and greatly improved lung function. It is concluded that heart and lung transplantation is a suitable treatment for selected patients with end stage chronic lung disease.